课题基金 / 基金详情

Task X6: Evaluation of a Leishmania Vaccine

Task X6: Evaluation of a Leishmania Vaccine
任务 X6：利什曼原虫疫苗的评估
批准号：
8753193
负责人：
NORMAN KNETEMAN
金额：
$53.8万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-09-17 至 2015-07-31
来源：
https://reporter.nih.gov/project-details/8753193
关键词：
BioterrorismClinicalCommunicable DiseasesContractsDevelopmentDrug resistanceEmerging Communicable DiseasesEvaluationFeasibility StudiesLeishmaniaPhaseSamplingServicesTestingToxicity TestsVaccinesassay developmentefficacy testingevaluation/testingimmunogenicitynovel vaccinespathogenproduct developmentsafety testingvaccine development

项目摘要

项目成果

NORMAN KNETEMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TASK A92: Efficacy testing of therapeutics against Hepatitis B in a mouse model
  • 批准号：
    9355867
  • 项目类别：
  • 资助金额：
    $84.28万
  • 财政年份：
    2016
  • 负责人：
    NORMAN KNETEMAN
  • 依托单位：
    KMT HEPATECH INC
Task B12: Comprehensive Virology Panel
  • 批准号：
    8744737
  • 项目类别：
  • 资助金额：
    $58.65万
  • 财政年份：
    2013
  • 负责人：
    NORMAN KNETEMAN
  • 依托单位：
    GEORGETOWN UNIVERSITY
Task A08: In Vitro Characterization Of Antimicrobial Activity
Task A03: In Vitro Screening for Antifungal Activity
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data